Cargando…
Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) has poor prognosis mainly due to lacking of effective diagnostic biomarkers. Aberrant expression of secreted phosphoprotein 1 (SPP1) protein has been observed in several cancers. The purpose of this study is to assess the feasibility of serum aut...
Autores principales: | Wang, Chen, Sun, Guiying, Wang, Huimin, Dai, Liping, Zhang, Jianying, Du, Renle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425987/ https://www.ncbi.nlm.nih.gov/pubmed/36038839 http://dx.doi.org/10.1186/s12885-022-10012-9 |
Ejemplares similares
-
Anti-CXCL8 Autoantibody: A Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma
por: Chen, Huili, et al.
Publicado: (2022) -
Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma
por: Wang, Huimin, et al.
Publicado: (2021) -
Anti-POSTN and Anti-TIMP1 Autoantibodies as Diagnostic Markers in Esophageal Squamous Cell Carcinoma
por: Xie, Weihong, et al.
Publicado: (2022) -
Identification of novel autoantibodies based on the protein chip encoded by cancer-driving genes in detection of esophageal squamous cell carcinoma
por: Sun, Guiying, et al.
Publicado: (2020) -
Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
por: Sun, Guiying, et al.
Publicado: (2019)